[Position paper of the Society of Pediatric Oncology and Hematology (GPOH) on (long-term) surveillance, (long-term) follow-up and late effect evaluation in pediatric oncology patients].
Calaminus
G
G
Heinrich-Heine-Universität Düsseldorf, Klinik für Kinder-Onkologie, -Hämatologie und Klinische Immunologie, Düsseldorf.
Kaatsch
P
P
D000359:Aftercare; D002423:Cause of Death; D002648:Child; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D005858:Germany; D006801:Humans; D007938:Leukemia / Q000401:mortality / Q000628:therapy*; D009369:Neoplasms / Q000401:mortality / Q000628:therapy*; D017063:Outcome Assessment, Health Care; D017410:Practice Guidelines as Topic; D012042:Registries; D012106:Research; D016019:Survival Analysis; D017741:Survivors